zadnja posodobitev :
08/11/2024
Infostab
Seznami
Seznami
Poiščite združljivosti
Tabela združljivosti Y-strani
Viri
raziskovalne skupine
valistab
poster
Povezave
sponzorji
Avtor
Navodilo za uporabo
Newsletter
Viri 472
Tip :
časopis
raziskovalne skupine :
Pierce - Lawn wood Regional Medical Center
Avtor :
Wohlford JG, Fowler MD.
Naslov :
Visual compatibility of hetastarch with injectable critical-care drugs.
Référence :
Am J Hosp Pharm ; 46: 995-996. 1989
Raven dokazov :
Fizikalna stabilnost :
Kemična stabilnost :
Druge metode :
Komentarji :
Seznami
Amikacin sulfate
5 mg/ml
+
Hetastarch
60 mg/ml
+
Ampicillin sodium
20 mg/ml
+
Hetastarch
60 mg/ml
+
Cefalotin sodium
20 mg/ml
+
Hetastarch
60 mg/ml
+
Cefamandole nafate
20 mg/ml
+
Hetastarch
60 mg/ml
+
Cefazolin sodium
20 mg/ml
+
Hetastarch
60 mg/ml
+
Cefonicid sodium
20 mg/ml
+
Hetastarch
60 mg/ml
+
Cefoperazone sodium
20 mg/ml
+
Hetastarch
60 mg/ml
+
Cefotaxime sodium
20 mg/ml
+
Hetastarch
60 mg/ml
+
Cefoxitin sodium
20 mg/ml
+
Hetastarch
60 mg/ml
+
Cimetidine hydrochloride
6 mg/ml
+
Hetastarch
60 mg/ml
+
Doxycycline hyclate
1 mg/ml
+
Hetastarch
60 mg/ml
+
Gentamicin sulfate
0.8 mg/ml
+
Hetastarch
60 mg/ml
+
Hetastarch
60 mg/ml
+
Amikacin sulfate
5 mg/ml
+
60 mg/ml
+
Ampicillin sodium
20 mg/ml
+
60 mg/ml
+
Cefalotin sodium
20 mg/ml
+
60 mg/ml
+
Cefamandole nafate
20 mg/ml
+
60 mg/ml
+
Cefazolin sodium
20 mg/ml
+
60 mg/ml
+
Cefonicid sodium
20 mg/ml
+
60 mg/ml
+
Cefoperazone sodium
20 mg/ml
+
60 mg/ml
+
Cefotaxime sodium
20 mg/ml
+
60 mg/ml
+
Cefoxitin sodium
20 mg/ml
+
60 mg/ml
+
Cimetidine hydrochloride
6 mg/ml
+
60 mg/ml
+
Doxycycline hyclate
1 mg/ml
+
60 mg/ml
+
Gentamicin sulfate
0.8 mg/ml
+
60 mg/ml
+
Ranitidine hydrochloride
0.5 mg/ml
+
60 mg/ml
+
Theophylline
4 mg/ml
+
60 mg/ml
+
Tobramycin sulfate
0.8 mg/ml
+
Ranitidine hydrochloride
0.5 mg/ml
+
Hetastarch
60 mg/ml
+
Theophylline
4 mg/ml
+
Hetastarch
60 mg/ml
+
Tobramycin sulfate
0.8 mg/ml
+
Hetastarch
60 mg/ml
+
Mentions Légales
